660 related articles for article (PubMed ID: 9384405)
1. Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.
Doğan A; Rao AM; Başkaya MK; Rao VL; Rastl J; Donaldson D; Dempsey RJ
J Neurosurg; 1997 Dec; 87(6):921-6. PubMed ID: 9384405
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-D-aspartate receptor antagonist, after experimental traumatic brain injury in rats.
Dempsey RJ; Başkaya MK; Doğan A
Neurosurgery; 2000 Aug; 47(2):399-404; discussion 404-6. PubMed ID: 10942013
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of ifenprodil on ischemic injury size, blood-brain barrier breakdown, and edema formation in focal cerebral ischemia.
Başkaya MK; Rao AM; Donaldson D; Prasad MR; Dempsey RJ
Neurosurgery; 1997 Feb; 40(2):364-70; discussion 370-1. PubMed ID: 9007871
[TBL] [Abstract][Full Text] [Related]
4. Dextrorphan reduces infarct volume, vascular injury, and brain edema after ischemic brain injury.
Du C; Hu R; Hsu CY; Choi DW
J Neurotrauma; 1996 Apr; 13(4):215-22. PubMed ID: 8860202
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
6. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
Tatlisumak T; Takano K; Meiler MR; Fisher M
Stroke; 1998 Jan; 29(1):190-5. PubMed ID: 9445350
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats.
Matsuo Y; Mihara Si ; Ninomiya M; Fujimoto M
Stroke; 2001 Sep; 32(9):2143-8. PubMed ID: 11546909
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia.
Rak R; Chao DL; Pluta RM; Mitchell JB; Oldfield EH; Watson JC
J Neurosurg; 2000 Apr; 92(4):646-51. PubMed ID: 10761655
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
Takaoka S; Bart RD; Pearlstein R; Brinkhous A; Warner DS
J Cereb Blood Flow Metab; 1997 Feb; 17(2):161-7. PubMed ID: 9040495
[TBL] [Abstract][Full Text] [Related]
10. Reduction of vasogenic edema and infarction by MK-801 in rats after temporary focal cerebral ischemia.
Yang G; Chan PH; Chen SF; Babuna OA; Simon RP; Weinstein PR
Neurosurgery; 1994 Feb; 34(2):339-45; discussion 345. PubMed ID: 8177396
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of memantine against ischemia-reperfusion injury in spontaneously hypertensive rats.
Dogan A; Eras MA; Rao VL; Dempsey RJ
Acta Neurochir (Wien); 1999; 141(10):1107-13. PubMed ID: 10550658
[TBL] [Abstract][Full Text] [Related]
12. Intra-artery infusion of recombinant human erythropoietin reduces blood-brain barrier disruption in rats following cerebral ischemia and reperfusion.
Wang R; Wu X; Liang J; Qi Z; Liu X; Min L; Ji X; Luo Y; Zhao H
Int J Neurosci; 2015; 125(9):693-702. PubMed ID: 25226558
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies.
Williams AJ; Dave JR; Phillips JB; Lin Y; McCabe RT; Tortella FC
J Pharmacol Exp Ther; 2000 Jul; 294(1):378-86. PubMed ID: 10871336
[TBL] [Abstract][Full Text] [Related]
14. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B
J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668
[TBL] [Abstract][Full Text] [Related]
15. Treatment of focal cerebral ischemia with synthetic oligopeptide corresponding to lectin domain of selectin.
Morikawa E; Zhang SM; Seko Y; Toyoda T; Kirino T
Stroke; 1996 May; 27(5):951-5; discussion 956. PubMed ID: 8623118
[TBL] [Abstract][Full Text] [Related]
16. Hypothermic protection in rat focal ischemia models: strain differences and relevance to "reperfusion injury".
Ren Y; Hashimoto M; Pulsinelli WA; Nowak TS
J Cereb Blood Flow Metab; 2004 Jan; 24(1):42-53. PubMed ID: 14688615
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of agmatine in rats with transient cerebral ischemia using MR imaging and histopathologic evaluation.
Huang YC; Tzeng WS; Wang CC; Cheng BC; Chang YK; Chen HH; Lin PC; Huang TY; Chuang TJ; Lin JW; Chang CP
Magn Reson Imaging; 2013 Sep; 31(7):1174-81. PubMed ID: 23642800
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia.
Kumon Y; Kim SC; Tompkins P; Stevens A; Sakaki S; Loftus CM
J Neurosurg; 2000 May; 92(5):848-52. PubMed ID: 10794300
[TBL] [Abstract][Full Text] [Related]
19. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
Vakili A; Hosseinzadeh F; Sadogh T
Brain Res; 2007 Sep; 1170():97-102. PubMed ID: 17698046
[TBL] [Abstract][Full Text] [Related]
20. mGluR1 antagonist decreases tyrosine phosphorylation of NMDA receptor and attenuates infarct size after transient focal cerebral ischemia.
Murotomi K; Takagi N; Takayanagi G; Ono M; Takeo S; Tanonaka K
J Neurochem; 2008 Jun; 105(5):1625-34. PubMed ID: 18248625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
